Company: MDCXW
Filing Date: 2025-03-28
Form Type: 253G2
Source: 0001062993-25-006502
Chunk: 161

Company: Medicus Pharma Ltd.
Filing Date: 2025-03-28
Form: 253G2
Chunk 161
---
 Medicus Pharma Ltd. (the "Company") on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

| Date: March 28, 2025 | By: | /s/ Raza Bokhari                               |
|:---------------------|:----|:-----------------------------------------------|
|                      |     | Dr. Raza Bokhari                               |
|                      |     | Executive Chairman and Chief Executive Officer |
|                      |     | -Principal Executive Officer                   |

Exhibit 32.2

<div align='center'>CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</div>

In connection with the Annual Report of Medicus Pharma Ltd. (the "Company") on Form 10-K for the period ending December 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I certify, in the capacity and on the date indicated below, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

| Date: March 28, 2025 | By: | /s/ James Quinlan                           |
|:---------------------|:----|:--------------------------------------------|
|                      |     | James Quinlan                               |
|                      |     | Chief Financial Officer                     |
|                      |     | -Principal